Could tumor spread through air spaces benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-institutional study

by Donglai Chen, Xiaofan Wang, Fuquan Zhang, Ruoshuang Han, Qifeng Ding, Xuejun Xu, Jian Shu, Fei Ye, Li Shi, Yiming Mao, Yongbing Chen, Chang Chen
Published 2020-12-01

Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC

by Sangtian Liu, Fengying Wu, Xuefei Li, Chao Zhao, Yijun Jia, Keyi Jia, Ruoshuang Han, Meng Qiao, Wei Li, Jia Yu, Fei Zhou, Anwen Xiong, Bin Chen, Jue Fan, Shengxiang Ren, Caicun Zhou
Published 2021-03-01